Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective randomized double-blind placebo-controlled phase IIb trial of vaginal Lactobacillus live capsule KAL-001 following metronidazole for treatment of bacterial vaginosis
CTR20240668Phase 2Completed
- Sponsor
- Anaerobio
- Start
- Feb 2024
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of KAL_001 in bacterial vaginosis (BV), sponsored by Anaerobio. Started Feb 2024; status: completed.
02
Drugs
KAL_001
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on CTR20240668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240668.